Publications by authors named "Fengqi Yan"

Claim this Profile
L
Laparoscopic aspirator bracket: a new instrument facilitating the aspiration and exposure of operative field simultaneously in laparoscopic nephron-sparing surgery.
Fengqi Yan, Xiaoliang Dou, Guangfeng Zhu, Qisheng Tang, Bo Zhang

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic inguinal lymphadenectomy for high-risk cN0 penile cancer: The optimal surgical timing.
Shanjin Ma, Jian Zhao, Zhiwei Liu, Tao Wu, Sheng Wang, Yanjun Wang, Fengqi Yan

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi.
Dong Cui, Fengqi Yan, JiangPu Yi, Dali He, Yichen Zhang

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis negative modulation of the HIF-2α-CYR61 axis.
Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan

Cancer Biol Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cistanoside of ameliorates hypoxia-induced male reproductive damage via suppression of oxidative stress.
Fengqi Yan, Xiaoliang Dou, Guangfeng Zhu, Mingyuan Xia, Yahui Liu

Am J Transl Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a/b-5p-KLF17 axis.
Wei Hu, Fengqi Yan, Yi Ru, Mingyuan Xia, Guang Yan

Am J Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.
Jianxin Ni, Fengqi Yan, Weijun Qin, Lei Yu, Geng Zhang, Xiaojian Yang, Bo Yang

Sci Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.
Guang Yan, Yi Ru, Fengqi Yan, Xin Xiong, Wei Hu

Cell Commun Signal· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.
Yao Zhang, Weifeng Lv, Qi Li, Qinhao Wang, Yi Ru, Fengqi Yan

Mol Med Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.
Guang Yan, Yi Ru, Fengqi Yan, Xin Xiong, Wei Hu

Cell Commun Signal· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Sfrp2 contributes to the neurological disorders related with morphine withdrawal via Wnt/β-catenin signaling.
Jian-Cai Wang, Yu-Qian Li, Da-Yun Feng, Xin Zhou, Feng-Qi Yan, Yang Li

Behav Brain Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3β Inhibitor Alsterpaullone Attenuates MPP-Induced Cell Damage in a c-Myc-Dependent Manner in SH-SY5Y Cells.
Jiancai Wang, Yuqian Li, Li Gao, Fengqi Yan, Guodong Gao

Front Cell Neurosci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Guang Yan, Yi Ru, Kerong Wu, Fengqi Yan, Qinhao Wang

Prostate· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.
Fengqi Yan, Xia Li, Nan Li, Rui Zhang, Qinhao Wang

Cancer Lett· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis